Skip to main content

Advertisement

Log in

Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC)

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The National Cancer Institute has highlighted the need for psychosocial research to focus on Black cancer patients. This applies to Black men with prostate cancer, as there is little systematic research concerning psychological distress in these men. This study was designed to validate the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer to help facilitate research within this group.

Methods

At three institutions, Black men with prostate cancer (n = 101) completed the MAX-PC, the Hospital Anxiety and Depression Scale (HADS), the Functional Assessment of Cancer Therapy (FACT) Quality of Life Questionnaire, and the Distress Thermometer.

Results

The average age of the 101 men was 66 (SD = 10) and 58 % had early-stage disease. The MAX-PC and its subscales (Prostate Cancer Anxiety, PSA Anxiety, and Fear of Recurrence) produced strong coefficient alphas (0.89, 0.88, 0.71, and 0.77, respectively). Factor analysis supported the three-factor structure of the scale established in earlier findings. The MAX-PC also demonstrated strong validity. MAX-PC total scores correlated highly with the Anxiety subscale of the HADS (r = 0.59, p < 0.01) and the FACT Emotional Well-Being subscale (r = −0.55, p < 0.01). Demonstrating discriminant validity, the correlation with the HADS Depression subscale (r = 0.40, p < 0.01) and the CES-D (r = 0.42, p < 0.01) was lower compared to that with the HADS Anxiety subscale.

Conclusions

The MAX-PC is valid and reliable in Black men with prostate cancer. We hope the validation of this scale in Black men will help facilitate psychosocial research in this group that is disproportionately adversely affected by this cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. ACS, Cancer Facts and Figures. 2015, American Cancer Society: Atlanta.

  2. Bennett GG, Badger TATA (2005) Depression in men with prostate cancer. Oncol Nurs Forum 32(3):545–556

    Article  PubMed  Google Scholar 

  3. Cliff AM, MacDonagh RP (2000) Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 86(7):834–839

    Article  CAS  PubMed  Google Scholar 

  4. Dale W et al. (2005) The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer 104(3):467–478

    Article  PubMed  PubMed Central  Google Scholar 

  5. Nordin KK et al. (2001) Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer 37(3):376

    Article  CAS  PubMed  Google Scholar 

  6. Ravi P et al. (2014) Mental health outcomes in elderly men with prostate cancer. Urol Oncol 32(8):1333–1340

    Article  PubMed  Google Scholar 

  7. Anai S et al. (2006) Prostate cancer screening and detection in inner-city and underserved men. J Natl Med Assoc 98(4):515–519

    PubMed  PubMed Central  Google Scholar 

  8. Moul JW et al. (1995) Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. AMAJama 274(16):1277–1281

    CAS  Google Scholar 

  9. Shuch B et al. (2004) Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol 22(23):4725–4729

    Article  CAS  PubMed  Google Scholar 

  10. Roth AJ et al. (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82(10):1904–1908

    Article  CAS  PubMed  Google Scholar 

  11. Zabora J et al. (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28

    Article  CAS  PubMed  Google Scholar 

  12. Roth A et al. (2006) Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 47(4):340–347

    Article  PubMed  Google Scholar 

  13. Roth AJ et al. (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer 97(11):2910–2918

    Article  PubMed  Google Scholar 

  14. Pierce RR et al. (2003) Prostate cancer and psychosocial concerns in African American men: literature synthesis and recommendations. Health & Social Work 28(4):302

    Article  Google Scholar 

  15. Nelson CJ, Balk EM, Roth AJ (2010) Distress, anxiety, depression, and emotional well-being in African-American men with prostate cancer. Psychooncology 19(10):1052–1060

    Article  PubMed  Google Scholar 

  16. Kornblith AB, Holland JC (1996) Model for quality-of-life research from the Cancer and Leukemia Group B: the telephone interview, conceptual approach to measurement, and theoretical framework. J Natl Cancer Inst Monogr 20

  17. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370

    Article  CAS  PubMed  Google Scholar 

  18. Radloff LS (1977) The CES-D: a self-report depression scale for research in the general population. Appl Psychol Meas 1(June):385–401

    Article  Google Scholar 

  19. Cella DF et al. (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579

    CAS  PubMed  Google Scholar 

  20. Karnofsky DA and Buchenal JH, The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents. MacLeod CM, Editor. 1949, Columbia University Press: New York. p. 191–205.

  21. Nunnally, J.C. and I.H. Bernstein, Psychometric theory. 3rd ed. 1994, New York: McGraw-Hill.

  22. Campbell DT, Fiske DW (1959) Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56(2):81–105

    Article  CAS  PubMed  Google Scholar 

  23. Gorusch, R.L., Factor analysis. 2nd ed. ed. 1983, Hillsdale, NJ: Lawrence Erlbaum Associates.

  24. MacCallum, R.C., et al., Sample size in factor analysis. In: Psychological methods. 1999. p. 84–99.

  25. Underwood W 3rd et al. (2005) Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 103(3):538–545

    Article  PubMed  Google Scholar 

  26. Kao AC et al. (1998) The relationship between method of physician payment and patient trust. JAMA 280(19):1708–1714

    Article  CAS  PubMed  Google Scholar 

  27. Krieger N et al. (2005) Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med 61(7):1576–1596

    Article  PubMed  Google Scholar 

  28. Dale W, Hemmerich J, Meltzer D (2007) Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population. Psychooncology 16(5):493–498

    Article  PubMed  Google Scholar 

  29. Consedine NS (2012) Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups. Am J Mens Health 6(1):37–50

    Article  PubMed  Google Scholar 

  30. Lepore SJ et al. (2012) Informed decision making about prostate cancer testing in predominantly immigrant black men: a randomized controlled trial. Ann Behav Med 44(3):320–330

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Funding for this study was provided by the Martell Foundation and grant #5R01-CA-85229.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian J. Nelson.

Ethics declarations

Conflict of interest

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us.

We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication and the respect to intellectual property. In so doing, we confirm that we have followed the regulations of our institutions concerning intellectual property.

We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within this manuscript.

We understand that the Corresponding Author is the sole contact for the Editorial process (including the Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions, and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nelson, C.J., Starr, T.D., Macchia, R.J. et al. Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Support Care Cancer 24, 2905–2911 (2016). https://doi.org/10.1007/s00520-016-3092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3092-7

Keywords

Navigation